• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Meta Materials Inc. - Common Stock (NQ:MMAT)

0.5258 UNCHANGED
Last Price Updated: 4:00 PM EDT, Aug 20, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Meta Materials Inc. - Common Stock

< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
22 23 Next >
News headline image
SEC Names Meta Materials in Pump-and-Dump Scheme Lawsuit ↗
December 14, 2022
Meta Materials and Torchlight Energy have been named in a SEC lawsuit against eight individuals, including @MrZackMorris and @PJ_Matlock. 
Via InvestorPlace
News headline image
JetBlue Airways, Pacira BioSciences And Some Other Big Stocks Moving Lower On Tuesday ↗
December 13, 2022
U.S. stocks traded slightly higher, with the Nasdaq Composite gaining around 70 points on Tuesday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
News headline image
Is Meta Materials (MMTLP) Stock Getting Deleted Today? ↗
December 13, 2022
Will MMTLP stock be deleted today? That's on the mind of every single shareholder after the surprise halt last week. 
Via InvestorPlace
News headline image
Moderna (MRNA) Stock Soars on Cancer Vaccine News ↗
December 13, 2022
Moderna (MRNA) stock is rising higher on Tuesday following the release of data from a Phase 2B cancer vaccine clinical trial. 
Via InvestorPlace
12 Information Technology Stocks Moving In Tuesday's Pre-Market Session ↗
December 13, 2022
 
Via Benzinga
News headline image
Why Investors Should Bet $100 on MMAT Stock ↗
December 09, 2022
MMAT stock investors can ignore the spinoff hubbub and focus on Meta Materials' niche-industry growth potential. 
Via InvestorPlace
News headline image
Insider Thomas Welch Just Sold Meta Materials (MMAT) Stock ↗
December 12, 2022
On December 7, 10% owner Thomas Welch sold 75,000 shares of MMAT stock at an average price of $2.23 per share. 
Via InvestorPlace
News headline image
Investors Petition for FINRA to Reinstate MMTLP Stock Trading After Halt ↗
December 12, 2022
MMTLP stock holders received a surprise last week when trading of the security was suspended. Now, shareholders have created a petition. 
Via InvestorPlace
News headline image
Why Harpoon Therapeutics Shares Are Trading Higher By 97%? Here Are 53 Stocks Moving In Monday's Mid-Day Session ↗
December 12, 2022
Gainers HTG Molecular Diagnostics, Inc. (NASDAQ: HTGM) shares jumped 165.7% to $1.4350 after jumping around 118% on Friday. HTG Molecular Diagnostics, last month, posted a Q3 loss of $0.41 per share. 
Via Benzinga
News headline image
Why Aptevo Therapeutics Shares Are Trading Higher By More Than 100%; Here Are 28 Stocks Moving Premarket ↗
December 12, 2022
Gainers 
Via Benzinga
News headline image
12 Information Technology Stocks Moving In Monday's Pre-Market Session ↗
December 12, 2022
 
Via Benzinga
News headline image
Halted Stocks Alert: Why Did FINRA Halt MMTLP Stock? ↗
December 09, 2022
Some shareholders are angry as trading in MMTLP stock is halted ahead of Meta Materials' planned spinoff of Next Bridge Hydrocarbons. 
Via InvestorPlace
News headline image
FINRA Halts Trading in Meta Materials (MMTLP) Stock Ahead of Spinoff ↗
December 09, 2022
FINRA has halted trading on MMTLP stock ahead of Meta Materials' Next Bridge Hydrocarbons spinoff. Here's what investors need to know. 
Via InvestorPlace
News headline image
Why Ambrx Biopharma Shares Are Trading Higher By Over 550%? Here Are 52 Stocks Moving In Friday's Mid-Day Session ↗
December 09, 2022
Gainers Ambrx Biopharma Inc. (NYSE: AMAM) shares jumped 551.4% to $2.67 after the company announced preliminary Phase 2 results from its ACE-Breast-03 study showing a 57.1% overall response rate. 
Via Benzinga
News headline image
Most Active Equity Options For Midday - Friday, Dec. 9 ↗
December 09, 2022
Here are the most active equity options for midday. 
Via Talk Markets
12 Information Technology Stocks Moving In Friday's Intraday Session ↗
December 09, 2022
 
Via Benzinga
News headline image
Lululemon, Li Auto, Hackett Group And Some Other Big Stocks Moving Lower On Friday ↗
December 09, 2022
U.S. stocks traded lower, with the Dow Jones jumping around 70 points on Friday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
News headline image
5 Investors Betting Big on Meta Materials (MMAT) Stock Right Now ↗
December 08, 2022
The date of record for the MMAT stock spinoff of MMTLP shares for shares of Next Bridge Hydrocarbons is quickly approaching. 
Via InvestorPlace
News headline image
Meta Materials Announces FINRA Has Revised Corporate Action for Exchange of Series A Preferred
December 08, 2022
Via ACCESSWIRE
12 Information Technology Stocks Moving In Thursday's Intraday Session ↗
December 08, 2022
 
Via Benzinga
News headline image
Chefs' Warehouse, Chart Industries And Some Other Big Stocks Moving Lower On Thursday ↗
December 08, 2022
U.S. stocks traded higher, with the Dow Jones jumping over 200 points on Thursday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
12 Information Technology Stocks Moving In Thursday's Pre-Market Session ↗
December 08, 2022
 
Via Benzinga
News headline image
Most Active Equity Options For Midday - Wednesday, Dec. 7 ↗
December 07, 2022
Here are the most active equity options for midday. 
Via Talk Markets
News headline image
Why Is TransCode Therapeutics (RNAZ) Stock Up 148% Today? ↗
December 07, 2022
TransCode Therapeutics (RNAZ) stock is rallying higher on Wednesday after the company withdrew plans for a secondary offering. 
Via InvestorPlace
News headline image
Why Prometheus Biosciences Shares Are Trading Higher By Over 184%? Here Are 55 Stocks Moving In Wednesday's Mid-Day Session ↗
December 07, 2022
Gainers Prometheus Biosciences, Inc. (NASDAQ: RXDX) shares jumped 184.2% to $102.49 after the company announced results for PRA023 in both ARTEMIS-UC Phase 2 and APOLLO-CD Phase 2a studies. ARTEMIS-UC... 
Via Benzinga
News headline image
SNY Stock Alert: Why 1 Analyst Says Zantac Ruling Is ‘Best-Case Scenario’ for Drugmakers ↗
December 07, 2022
Sanofi (SNY) stock is in the news as one analyst believes the latest court ruling is the "best-case scenario" for the drugmaker. 
Via InvestorPlace
News headline image
Why Is Meta Materials (MMAT) Stock Up 9% Today? ↗
December 07, 2022
Shares of MMAT stock are in the green after it was announced that FINRA had approved the exchange to receive Next Bridge shares. 
Via InvestorPlace
News headline image
What's Going On With Meta Materials Stock Today? ↗
December 07, 2022
Shares of Meta Materials Inc (NASDAQ: MMAT) and Meta Materials Preferred (Pink: MMTLP) are trading higher Wednesday after the company announced FINRA has processed corporate actions for the exchange of... 
Via Benzinga
News headline image
12 Information Technology Stocks Moving In Wednesday's Pre-Market Session ↗
December 07, 2022
 
Via Benzinga
News headline image
Why iBio Shares Are Trading Lower By Around 48%; Here Are 23 Stocks Moving Premarket ↗
December 07, 2022
Gainers TransCode Therapeutics, Inc. (NASDAQ: RNAZ) shares rose 71.3% to $0.7190 in pre-market trading after the company reported withdrawal of registration statement. 
Via Benzinga
< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
22 23 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap